Singapore markets closed
Straits Times Index
3,330.01 -8.93 (-0.27%) S&P 500
5,315.10 +23.76 (+0.45%) Dow
38,624.55 -86.74 (-0.22%) Nasdaq
17,041.10 +184.05 (+1.09%) Bitcoin USD
70,972.64 +1,383.59 (+1.99%) CMC Crypto 200
1,511.75 +38.01 (+2.58%)
Walvax Biotechnology Co., Ltd. (300142.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
At close: 03:04PM CST
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 20.69B |
| Enterprise value | 17.39B |
| Trailing P/E | 78.84 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.32 |
| Price/book (mrq) | 2.21 |
| Enterprise value/revenue | 4.48 |
| Enterprise value/EBITDA | 38.33 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.69 |
| 52-week change 3 | -52.33% |
| S&P500 52-week change 3 | 23.99% |
| 52-week high 3 | 28.45 |
| 52-week low 3 | 12.74 |
| 50-day moving average 3 | 14.71 |
| 200-day moving average 3 | 20.19 |
Share statistics
| Avg vol (3-month) 3 | 16.49M |
| Avg vol (10-day) 3 | 13.56M |
| Shares outstanding 5 | 1.61B |
| Implied shares outstanding 6 | 1.61B |
| Float 8 | 1.38B |
| % held by insiders 1 | 14.36% |
| % held by institutions 1 | 14.78% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.01 |
| Forward annual dividend yield 4 | 0.08% |
| Trailing annual dividend rate 3 | 0.01 |
| Trailing annual dividend yield 3 | 0.08% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 6.12% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 30 May 2024 |
| Last split factor 2 | 30:10 |
| Last split date 3 | 14 Oct 2015 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 6.74% |
| Operating margin (ttm) | 19.94% |
Management effectiveness
| Return on assets (ttm) | 2.63% |
| Return on equity (ttm) | 3.11% |
Income statement
| Revenue (ttm) | 3.88B |
| Revenue per share (ttm) | 2.42 |
| Quarterly revenue growth (yoy) | -28.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 949.11M |
| Net income avi to common (ttm) | 261.53M |
| Diluted EPS (ttm) | 0.16 |
| Quarterly earnings growth (yoy) | -91.80% |
Balance sheet
| Total cash (mrq) | 4.11B |
| Total cash per share (mrq) | 2.57 |
| Total debt (mrq) | 804.68M |
| Total debt/equity (mrq) | 7.04% |
| Current ratio (mrq) | 2.85 |
| Book value per share (mrq) | 5.86 |
Cash flow statement
| Operating cash flow (ttm) | 854.98M |
| Levered free cash flow (ttm) | -79.96M |
© 2024 Yahoo. All rights reserved.